The study utilized a retrospective analysis of electronic health records to extract detailed information about insurance status. Insurance churn was operationalized as a sequence whereby patients who were previously insured experienced at least two consecutive clinical visits during which they lacked coverage. This method enabled researchers to identify not just momentary lapses but more persistent gaps in insurance that could undermine continuous access to medical care. Approximately 39,500 individuals within the cohort lost their health insurance at some point during the study period, providing a robust dataset for evaluating risk factors associated with coverage loss.

One of the study’s key revelations was that patients diagnosed with diabetes were 25% more likely to lose health insurance coverage compared to their non-diabetic counterparts. Moreover, among those with diabetes, individuals with more complex disease profiles—characterized by poor glycemic control, multiple medication regimens, or diabetes-related complications—faced an even greater risk of becoming uninsured. These findings challenge prior assumptions about healthcare engagement, as conventional wisdom would suggest that patients managing chronic illness might be more motivated or supported in maintaining insurance coverage.

The corresponding author of the study, Dr. Nathalie Huguet, an associate professor of family medicine at OHSU, expressed surprise at this result. “We had hypothesized that people with diabetes, given their higher medical needs and presumably greater interaction with healthcare systems, would maintain more stable insurance coverage,” she said. Instead, the data revealed significant instability, pointing to systemic barriers that disproportionately impact vulnerable populations with chronic diseases. This instability poses a threat not only to individual health outcomes but also to broader public health objectives.

Insurance churn carries profound implications for the continuity of care, a cornerstone of effective diabetes management. The episodic loss of coverage can lead to interruptions in medication adherence, delayed clinical interventions, and increased reliance on costly emergency services. These disruptions may exacerbate disease progression and heighten the risk of complications such as cardiovascular events, neuropathy, and renal failure. The study’s evidence underscores the urgency of designing policies that promote sustained insurance coverage, particularly for populations with complex medical needs.

Alarmingly, the study also demonstrated that many patients who experienced insurance loss did not regain coverage. Nearly half (46%) of diabetic patients who lost Medicaid insurance failed to re-enroll or obtain alternative coverage, while 61% of those disenrolled from private insurance remained uninsured. This phenomenon of prolonged uninsurance compromises access to preventive and routine care, undermining disease control and increasing downstream healthcare costs. The persistence of such gaps highlights critical deficiencies in existing safety nets and enrollment systems.

The research gains added urgency in light of recent historical events. Following the expiration of the public health emergency declaration related to the COVID-19 pandemic in May 2023, approximately 25 million people were disenrolled from Medicaid nationwide. Policymakers had anticipated that most of these individuals would transition seamlessly to other forms of insurance. However, the study’s findings suggest that these expectations may be overly optimistic given the documented challenges of re-enrollment, particularly for individuals with chronic illnesses like diabetes.

The dataset analyzed in this study encompasses years prior to the pandemic, yet Dr. Huguet plans to extend the research to evaluate post-pandemic trends, including the outcomes of the mass Medicaid disenrollment. Her ongoing work aims to probe whether insurance instability has worsened for high-risk groups and to identify mechanisms through which healthcare systems can better track and support these transitions. Advanced statistical modeling and health informatics will likely play key roles in uncovering these dynamics.

Importantly, some states’ strategies during the post-pandemic period provide potential models for mitigating insurance churn. Oregon, for instance, opted not to immediately disenroll eligible individuals from Medicaid, thus preserving more consistent coverage. According to Dr. Huguet, maintaining continuous enrollment through targeted policy interventions can stabilize healthcare access, reduce preventable hospitalizations, and ultimately control public healthcare expenditures. Insights from such policy experiments may inform national approaches to health insurance administration.

Going forward, Dr. Huguet advocates for improvements both in enrollment processes and patient navigation. Slower, more deliberate disenrollment procedures combined with personalized support systems could help individuals quickly identify and obtain alternative insurance plans, minimizing periods of uninsurance. Policymakers and healthcare providers must collaborate to design streamlined transitions and proactive outreach that prioritize patients with chronic conditions. Such reforms have the potential to reduce costly gaps in coverage and improve long-term health trajectories.

This study represents an important contribution to the literature on healthcare inequities by quantitatively demonstrating the link between diabetes and insurance loss risk. The large-scale, longitudinal electronic health record data adds rigor to the field’s understanding of insurance dynamics among socioeconomically disadvantaged populations. It also challenges simplistic assumptions that chronic illness automatically secures insurance stability, revealing instead a nuanced reality shaped by socioeconomic, medical, and policy factors.

In conclusion, as health systems continue to grapple with post-pandemic disruptions and evolving healthcare financing models, it is imperative to recognize that insurance instability disproportionately undermines continuity of care for people with diabetes. Ensuring uninterrupted insurance coverage is essential not only for individual well-being but also for the sustainability of healthcare delivery and cost control. This study signals urgent policy priorities and offers a research framework to evaluate and improve insurance stability for vulnerable patients nationwide.

Subject of Research: People

Article Title: Insurance Instability Among Community-Based Health Center Patients with Diabetes Post-Affordable Care Act Medicaid Expansion

News Publication Date: 16-Apr-2025

Web References: https://www.jabfm.org/content/early/2025/03/28/jabfm.2024.240186R1

Image Credits: Credit: OHSU

Keywords: Diabetes; Public health; Health insurance; Adults; Family medicine; Disease control; Drug costs

Preterm birth, defined as delivery before 37 weeks of gestation, complicates approximately 10% of births in the United States, equating to about 400,000 affected infants annually. This early arrival into the world disrupts normal pulmonary development, often resulting in compromised lung architecture that may predispose survivors to chronic respiratory difficulties. Among these are increased risks for wheezing, asthma, and recurrent hospitalizations due to respiratory illnesses, conditions that may persist well into adulthood and severely diminish quality of life. Existing therapies focus primarily on stabilizing respiratory distress immediately following birth, yet the optimal duration of such interventions—particularly CPAP—remains a contentious matter in neonatology.

CPAP, a noninvasive respiratory support technique that maintains positive airway pressure through nasal prongs or masks, has become standard practice for managing respiratory distress in neonates. While early initiation of CPAP is universally accepted, clinicians typically discontinue its use once overt breathing difficulties resolve. The OHSU research team sought to interrogate whether prolonging CPAP therapy beyond this point could foster improved lung maturation, hypothesizing that mechanical support aids alveolar development and enhances gas exchange capabilities in immature lungs.

Conducting a meticulously designed randomized controlled trial involving 100 stable preterm infants, the scientists extended the CPAP treatment by two additional weeks beyond standard care intervals. By doing so, they observed remarkable enhancements in several key pulmonary metrics. At a six-month follow-up post-discharge, infants who received extended CPAP exhibited significantly greater lung volumes, an established biomarker of improved lung growth and functional capacity. Moreover, these infants demonstrated superior oxygen and carbon dioxide diffusion efficiency, underscoring improved alveolar-capillary membrane integrity and pulmonary microstructure.

The study further revealed that infants treated with prolonged CPAP experienced fewer wheezing episodes during their first year, suggesting a durable protective effect against airway hyperreactivity and inflammation that commonly affect this vulnerable population. These findings imply that a relatively simple alteration in therapeutic duration can impart substantial benefits that extend well beyond the immediate neonatal period, potentially mitigating the risk of chronic respiratory disease in later life.

Importantly, the therapy evaluated is both accessible and readily implementable across NICUs globally. CPAP devices are standard equipment, requiring no novel pharmacological agents or invasive procedures, thereby offering a low-cost, scalable intervention. The OHSU Doernbecher Children’s Hospital has already adopted this extended CPAP protocol, reporting ongoing positive outcomes in their patient cohort. Several other NICUs nationwide are currently revisiting their CPAP management strategies in light of these compelling results.

Despite these promising revelations, the researchers caution that further studies are essential to delineate the optimal CPAP duration for varied strata within the preterm infant population. Infants with very low birth weights or additional co-morbidities may require tailored approaches, and longitudinal data are crucial to ascertain sustained respiratory benefits or potential unforeseen consequences. To that end, the investigative team plans to monitor the original trial cohort through age 10, employing annual lung function assessments to parse the long-term impact of extended CPAP therapy on pulmonary health trajectories.

Mechanistically, the findings align with emerging insights into lung developmental biology. The preterm lung is characterized by arrested alveolarization and reduced surface area for gas exchange. By providing a sustained distending pressure, CPAP may prevent atelectasis, maintain airway patency, and promote optimal mechanical stretch-induced signaling pathways pivotal for alveolar septation and vascularization. This mechanotransduction is vital for establishing robust, functional lung architecture capable of efficient respiration.

From a clinical standpoint, this research reframes our understanding of neonatal respiratory management, emphasizing that timing and duration of interventions are as critical as their presence. Extending CPAP therapy represents a nonpharmacological strategy that is safe, efficient, and capable of modifying the natural history of lung disease in preterm infants. Such interventions may ultimately reduce the burden of chronic respiratory ailments, health care costs, and improve life quality for patients born prematurely.

Dr. Cindy McEvoy, the principal investigator and a professor of pediatrics at OHSU’s School of Medicine, highlights the transformative potential of this work. She states, “Adjusting the duration of CPAP application offers a safe and actionable method to influence lung development positively. Our aim is to ensure these infants have the best possible respiratory outcomes throughout their lives.” Her statement underscores a shift towards proactive optimization of neonatal treatments beyond immediate survival, targeting lifelong health outcomes.

Dr. Dmitry Dukhovny, medical director of the NICU at OHSU Doernbecher Children’s Hospital, further emphasizes the accessibility of this intervention, noting its ubiquity in NICUs and ease of implementation. “By simply modifying how long we administer CPAP, we can profoundly impact lung function development. This study exemplifies how small changes in clinical practice can have outsized benefits,” he notes.

In summation, the OHSU study substantiates that prolonged CPAP administration in stable preterm infants results in enhanced lung growth, improved pulmonary gas exchange, and reduced respiratory morbidity during infancy. It heralds a new era in neonatal respiratory care, where treatment duration is intelligently tailored to optimize developmental outcomes. The broader neonatal community is poised to embrace these findings, with ongoing trials and longitudinal investigations anticipated to solidify extended CPAP as a new standard of care.

Subject of Research: Extended continuous positive airway pressure therapy and its effects on lung growth and function in preterm infants.

Article Title: Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial

Web References:
https://www.atsjournals.org/doi/10.1164/rccm.202411-2169OC
https://www.ohsu.edu/doernbecher/neonatal-intensive-care-unit-nicu

References:

• McEvoy, C. et al. (2024). Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. DOI: 10.1164/rccm.202411-2169OC

Keywords: Infants, Lungs, Respiration, Disease intervention, Clinical research

A study published in the peer-reviewed journal Scientific Reports explored how the diets of pregnant women during their second and third trimesters relate to behavioral and temperament outcomes in their children. Specifically, researchers aimed to understand the effects of consuming high-glycemic index (GI) foods, which cause rapid increases in blood sugar levels, on infant behavior. High-GI foods are widely available and commonly consumed, including items like white bread, sugary cereals, and snacks. This research adds to a growing body of literature that reveals essential connections between maternal health behaviors and the mental health of their children.

Conducted under the guidance of prominent figures in psychiatry and nutrition, such as Dr. Elinor Sullivan and Dr. Hanna Gustafsson, the study assessed the dietary intake of over 300 pregnant participants. Data was systematically gathered through detailed food frequency questionnaires, which allowed researchers to evaluate not only the quantities of food consumed but also their respective glycemic indices. With this data, they were able to create composite averages of dietary glycemic indices, enabling them to draw conclusions regarding the overall nutritional quality of each participant’s diet during crucial stages of pregnancy.

One particularly striking finding from the study is that the detrimental effects of high-glycemic index foods on behavioral outcomes in infants were most pronounced during the third trimester. This suggests that the final weeks of prenatal development may represent a sensitive period during which the developing fetal brain is particularly vulnerable to nutritional influences. The implications of these findings are both profound and urgent; health care practitioners can potentially mitigate the development of mental health disorders in children through targeted dietary interventions aimed at mothers.

Lead author Dr. Elizabeth Wood emphasizes the significance of these findings, asserting that they underscore the critical need for nutritional interventions during pregnancy. By identifying specific dietary patterns that correlate with improved infant behavioral health outcomes, health professionals can advise expectant mothers on making better food choices. This proactive approach could lead to a healthier developmental trajectory for infants, fostering better mental health in early life stages.

Moreover, Dr. Jamie Lo, a maternal-fetal medicine expert, noted the crucial opportunity for intervention that arises late in pregnancy. Highlighting that many women establish prenatal care only after the first trimester, this research advocates for increased awareness and resources focused on nutrition during the third trimester. Educating expecting mothers on the importance of diet can empower them to make informed choices that directly impact their children’s well-being.

This line of research does not solely address dietary concerns; it also points to broader socio-economic issues related to food accessibility and education. The need for policy modifications that enhance access to and knowledge about nutritious foods is underscored by the researchers. Furthermore, there is a call to integrate nutritional counseling into routine prenatal care, allowing healthcare providers to take a more holistic approach to maternal and infant health.

The Oregon Health & Science University Center for Women’s Health offers tools like the ‘My Pregnancy Plate’ model, which advocates for balanced, varied, and moderate eating habits during pregnancy. This resource aligns well with the findings of the research, framing healthy dietary choices as fundamental to ensuring the health of mothers and their babies. One-on-one counseling with registered dietitians is also available, providing personalized support that can cater to individual dietary preferences and restrictions.

As the field of maternal health continues to evolve, the insights gained from this research pave the way for future studies focused on optimizing maternal nutrition. By determining the best dietary patterns during pregnancy, researchers hope to significantly improve the long-term health of both mothers and children. The overarching goal of this research is not merely to identify risks but to lay the groundwork for actionable interventions that can alter the course of children’s lives for the better.

In conclusion, the vital relationship between maternal diet and infant mental health cannot be overstated. This emerging evidence suggests that altering dietary habits during pregnancy—especially in the third trimester—could result in tangible improvements in the mental health outcomes of future generations. As Dr. Sullivan aptly puts it, interventions made during pregnancy carry the potential to shape the health of not just one child but their descendants as well, marking a significant step forward in public health and preventive medicine.

Subject of Research: Maternal diet during pregnancy and its effect on offspring mental health
Article Title: Higher prenatal dietary glycemic index in the third trimester of pregnancy is associated with infant negative affect at 6 months
News Publication Date: July 1, 2024
Web References: Scientific Reports, OHSU Center for Mental Health Innovation
References: DOI: 10.1038/s41598-025-91886-0
Image Credits: Oregon Health & Science University
Keywords: Health and medicine, Human health, Human biology, Human reproduction, Mental health, Behavior disorders, Infants, Risk factors, Behavior modification, Diets, Nutrition.